Orbactiv: payments to doctors
Payments that named Orbactiv as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.1M
- Providers
- 6,872
- Transactions
- 20,899
- Average per transaction
- $52
The per-transaction average — $52 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 6,872 providers the average total is $160, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Melinta Therapeutics, LLC | $835,112 | 76.1% |
| Melinta Therapeutics, Inc. | $261,842 | 23.9% |